Analysts Set Johnson Matthey PLC (LON:JMAT) Price Target at GBX 2,707.14

Johnson Matthey PLC (LON:JMAT) has been assigned a consensus rating of “Hold” from the twelve analysts that are currently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and six have issued a buy rating on the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is GBX 2,707.14 ($33.31).

A number of research firms have commented on JMAT. Citigroup reissued a “buy” rating on shares of Johnson Matthey in a research note on Wednesday, June 3rd. Sanford C. Bernstein boosted their price target on shares of Johnson Matthey from GBX 3,400 ($41.84) to GBX 3,500 ($43.07) and gave the stock an “outperform” rating in a research note on Tuesday, July 14th. Morgan Stanley upped their price objective on shares of Johnson Matthey from GBX 2,700 ($33.23) to GBX 2,850 ($35.07) and gave the company an “overweight” rating in a research note on Monday, June 22nd. Barclays cut their price objective on shares of Johnson Matthey from GBX 2,650 ($32.61) to GBX 2,450 ($30.15) and set an “equal weight” rating for the company in a research note on Monday, July 6th. Finally, Deutsche Bank cut shares of Johnson Matthey to a “hold” rating and cut their price objective for the company from GBX 2,700 ($33.23) to GBX 2,200 ($27.07) in a research note on Friday, June 12th.

In other news, insider Robert MacLeod purchased 18 shares of the stock in a transaction that occurred on Wednesday, July 15th. The stock was bought at an average cost of GBX 2,302 ($28.33) per share, for a total transaction of £414.36 ($509.92). Also, insider Doug Webb purchased 2,400 shares of the stock in a transaction that occurred on Monday, June 15th. The shares were purchased at an average price of GBX 2,054 ($25.28) per share, with a total value of £49,296 ($60,664.53). Insiders have purchased a total of 2,454 shares of company stock valued at $5,046,204 over the last quarter.

JMAT stock traded down GBX 58 ($0.71) during midday trading on Tuesday, reaching GBX 2,239 ($27.55). The company had a trading volume of 741,421 shares, compared to its average volume of 691,012. The company has a debt-to-equity ratio of 50.71, a current ratio of 1.32 and a quick ratio of 0.71. Johnson Matthey has a 1 year low of GBX 20.77 ($0.26) and a 1 year high of GBX 3,294 ($40.54). The company has a market capitalization of $4.33 billion and a P/E ratio of 16.95. The firm has a 50-day moving average price of GBX 2,168.44 and a 200-day moving average price of GBX 2,233.71.

Johnson Matthey (LON:JMAT) last released its quarterly earnings results on Thursday, June 11th. The company reported GBX 199.20 ($2.45) EPS for the quarter, topping the Zacks’ consensus estimate of GBX 197.10 ($2.43) by GBX 2.10 ($0.03). On average, equities analysts predict that Johnson Matthey will post 24172.9994616 EPS for the current year.

The company also recently declared a dividend, which will be paid on Tuesday, August 4th. Investors of record on Thursday, June 18th will be issued a dividend of GBX 31.13 ($0.38) per share. This is a positive change from Johnson Matthey’s previous dividend of $24.50. This represents a yield of 1.52%. The ex-dividend date is Thursday, June 18th. Johnson Matthey’s dividend payout ratio is currently 42.39%.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

See Also: What is the LIBOR?

Analyst Recommendations for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with's FREE daily email newsletter.